Oncolytics Biotech (ONCY) Selling, General & Administrative (2010 - 2026)
Oncolytics Biotech's Selling, General & Administrative was $5.12 million in Q2 2026, up 87.1% from $2.74 million a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Oncolytics Biotech's Selling, General & Administrative was $14.48 million through Jun 30, 2026, up 47.4% year-over-year; for FY2025, it was $15.41 million, up 52.6% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $10.1 million in FY2024 (-15.3%), $11.92 million in FY2023 (+34.8%), $8.84 million in FY2022 (-16.8%) and $10.62 million in FY2021 (+13.7%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q3 2021.
- Compared with a year earlier, Selling, General & Administrative was higher in three of the last six quarters, with growth averaging 23.4%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2023 (growth of 113.9%); the worst was Q3 2024 (a decline of 41.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Oncolytics Biotech | 62.32 Mn | 33.44 Mn | - | 5.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.12 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 3.08 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 2.58 Mn |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 2.05 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Dec 31, 2020 | 446,691.22 |
| Jun 30, 2011 | 609,381.00 |
API Access
Oncolytics Biotech Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();